The AGE of the matrix: Chemistry, consequence and cure

Current Opinion in Pharmacology

Volumn 4, Issue 3, 2004, Pages 301-305

  DeGroot, Jeroen ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALAGEBRIUM; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSAMINE; LIPID; LIPOPROTEIN; N PHENACYL 4,5 DIMETHYLTHIAZOLIUM; N PHENACYLTHIAZOLIUM; PYRIDOXAMINE; SOLUBLE ADVANCED GLYCATION END PRODUCT RECEPTOR; SUGAR; UNCLASSIFIED DRUG;

AMADORI REARRANGEMENT; ARTICLE; BONE; DIABETES MELLITUS; GLYCATION; HEREDITY; HUMAN; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; RAT; SKIN; TENDON; TISSUE DISTRIBUTION;

EID: 2342648312     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.01.007     Document Type: Review

References (43)

1. Reiser K.M. Nonenzymatic glycation of collagen in aging and diabetes Proc Soc Exp Biol Med 218 1998 23-37
2. Januszewski A.S. Alderson N.L. Metz T.O. Thorpe S.R. Baynes J.W. Role of lipids in chemical modification of proteins and development of complications in diabetes Biochem Soc Trans 31 2003 1413-1416
3. Baynes J.W. Chemical modification of proteins by lipids in diabetes Clin Chem Lab Med 41 2003 1159-1165
4. Vlassara H. Cai W. Crandall J. Goldberg T. Oberstein R. Dardaine V. Peppa M. Rayfield E.J. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy Proc Natl Acad Sci USA 99 2002 15596-15601
5. Cerami C. Founds H. Nicholl I. Mitsuhashi T. Giordano D. Vanpatten S. Lee A. al-Abed Y. Vlassara H. Bucala R. Cerami A. Tobacco smoke is a source of toxic reactive glycation products Proc Natl Acad Sci USA 94 1997 13915-13920
6. Leslie R.D. Beyan H. Sawtell P. Boehm B.O. Spector T.D. Snieder H. Level of an advanced glycated end product is genetically determined: a study of normal twins Diabetes 52 2003 2441-2444
7. Sell D.R. Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process J Biol Chem 264 1989 21597-21602
8. Brock J.W. Hinton D.J. Cotham W.E. Metz T.O. Thorpe S.R. Baynes J.W. Ames J.M. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease J Proteome Res 2 2003 506-513
9. Zhang Y. Cocklin R.R. Bidasee K.R. Wang M. Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm J Biomol Tech 14 2003 224-230
10. Ahmed N. Thornalley P.J. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring Biochem Soc Trans 31 2003 1417-1422
11. Thornalley P.J. Battah S. Ahmed N. Karachalias N. Agalou S. Babaei-Jadidi R. Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry Biochem J 375 2003 581-592
12. Verzijl N. DeGroot J. Thorpe S.R. Bank R.A. Shaw J.N. Lyons T.J. Bijlsma J.W. Lafeber F.P. Baynes J.W. Tekoppele J.M. Effect of collagen turnover on the accumulation of advanced glycation end products J Biol Chem 275 2000 39027-39031
13. Verzijl N. DeGroot J. Ben Z.C. Brau-Benjamin O. Maroudas A. Bank R.A. Mizrahi J. Schalkwijk C.G. Thorpe S.R. Baynes J.W. et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis Arthritis Rheum 46 2002 114-123
14. Chen A.C. Temple M.M. Ng D.M. Verzijl N. DeGroot J. Tekoppele J.M. Sah R.L. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage Arthritis Rheum 46 2002 3212-3217
15. Bailey A.J. Sims T.J. Avery N.C. Miles C.A. Chemistry of collagen cross-links: glucose-mediated covalent cross- linking of type-IV collagen in lens capsules Biochem J 296 1993 489-496
16. Tomasek J.J. Meyers S.W. Basinger J.B. Green D.T. Shew R.L. Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats Life Sci 55 1994 855-861
17. Kesava R.G. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues J Orthop Res 21 2003 738-743
18. DeGroot J. Verzijl N. Wenting-van Wijk M.J.G. Bank R.A. Lafeber F.P. Bijlsma J.W. Tekoppele J.M. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products Arthritis Rheum 44 2001 2562-2571
19. Bouma B. Kroon-Batenburg L.M. Wu Y.P. Brunjes B. Posthuma G. Kranenburg O. de Groot P.G. Voest E.E. Gebbink M.F. Glycation induces formation of amyloid cross-beta structure in albumin J Biol Chem 278 2003 41810-41819
20. DeGroot J. Verzijl N. Budde M. Bijlsma J.W. Lafeber F.P. Tekoppele J.M. Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes Exp Cell Res 266 2001 303-310
21. DeGroot J. Verzijl N. Bank R.A. Lafeber F.P. Bijlsma J.W. Tekoppele J.M. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation Arthritis Rheum 42 1999 1003-1009
22. Taniguchi N. Kawahara K. Yone K. Hashiguchi T. Yamakuchi M. Goto M. Inoue K. Yamada S. Ijiri K. Matsunaga S. et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 48 2003 971-981
23. Hofmann M.A. Drury S. Hudson B.I. Gleason M.R. Qu W. Lu Y. Lalla E. Chitnis S. Monteiro J. Stickland M.H. et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun 3 2002 123-135
24. Valencia J.V. Weldon S.C. Quinn D. Kiers G.H. DeGroot J. Tekoppele J.M. Hughes T.E. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics Anal Biochem 324 2004 68-78
25. Lander H.M. Tauras J.M. Ogiste J.S. Hori O. Moss R.A. Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 272 1997 17810-17814
26. Taniguchi N. Kawahara K. Yone K. Hashiguchi T. Yamakuchi M. Goto M. Inoue K. Yamada S. Ijiri K. Matsunaga S. et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 48 2003 971-981
27. DeGroot J, Verzijl N, Wenting-van Wijk MJG, Jacobs KM, van Roermund PM, Bank RA, Tekoppele JM, Bijlsma JWJ, Lafeber FPJG: Accumulation of advanced glycation endproducts as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 2004, in press
28. Wautier M.P. Massin P. Guillausseau P.J. Huijberts M. Levy B. Boulanger E. Laloi-Michelin M. Wautier J.L. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients Diabetes Metab 29 2003 44-52
29. Hein G. Wiegand R. Lehmann G. Stein G. Franke S. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis Rheumatology (Oxford) 42 2003 1242-1246
30. Wu X. Monnier V.M. Enzymatic deglycation of proteins Arch Biochem Biophys 419 2003 16-24
31. Alderson N.L. Chachich M.E. Youssef N.N. Beattie R.J. Nachtigal M. Thorpe S.R. Baynes J.W. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats Kidney Int 63 2003 2123-2133
32. Metz T.O. Alderson N.L. Chachich M.E. Thorpe S.R. Baynes J.W. Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications J Biol Chem 278 2003 42012-42019
33. Voziyan P.A. Khalifah R.G. Thibaudeau C. Yildiz A. Jacob J. Serianni A.S. Hudson B.G. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions J Biol Chem 278 2003 46616-46624
34. Reginster J.Y. Deroisy R. Rovati L.C. Lee R.L. Lejeune E. Bruyere O. Giacovelli G. Henrotin Y. Dacre J.E. Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 2001 251-256
35. Zerkak D. Dougados M. The use of glucosamine therapy in osteoarthritis Curr Rheumatol Rep 6 2004 41-45
36. Vasan S. Zhang X. Kapurniotu A. Bernhagen J. Teichberg S. Basgen J. Wagle D. Shih D. Terlecky I. Bucala R. Cerami A. et al. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo Nature 382 1996 275-278
37. Thornalley P.J. Minhas H.S. Rapid hydrolysis and slow alpha, beta-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links Biochem Pharmacol 57 1999 303-307
38. Kass D.A. Shapiro E.P. Kawaguchi M. Capriotti A.R. Scuteri A. deGroof R.C. Lakatta E.G. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker Circulation 104 2001 1464-1470
39. Liu J. Masurekar M.R. Vatner D.E. Jyothirmayi G.N. Regan T.J. Vatner S.F. Meggs L.G. Malhotra A. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart Am J Physiol Heart Circ Physiol 285 2003 H2587-H2591
40. Forbes J.M. Thallas V. Thomas M.C. Founds H.W. Burns W.C. Jerums G. Cooper M.E. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes FASEB J 17 2003 1762-1764
41. Yang S. Litchfield J.E. Baynes J.W. AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats Arch Biochem Biophys 412 2003 42-46
42. Hudson B.I. Bucciarelli L.G. Wendt T. Sakaguchi T. Lalla E. Qu W. Lu Y. Lee L. Stern D.M. Naka Y. et al. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch Biochem Biophys 419 2003 80-88
43. Hofmann M.A. Drury S. Hudson B.I. Gleason M.R. Qu W. Lu Y. Lalla E. Chitnis S. Monteiro J. Stickland M.H. et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun 3 2002 123-135